A pilot study of (13)N-ammonia cardiac PET imaging to assess subacute cardiotoxicity following adjuvant intensity-modulated radiotherapy for locally advanced breast cancer Journal Article


Authors: Nehmeh, S. A.; Fox, J. J.; Schwartz, J.; Ballangrud, Å M.; Schöder, H.; Zhao, Y.; Strauss, H. W.; Yu, A.; Gupta, D.; Powell, S. N.; Ho, A. Y.
Article Title: A pilot study of (13)N-ammonia cardiac PET imaging to assess subacute cardiotoxicity following adjuvant intensity-modulated radiotherapy for locally advanced breast cancer
Abstract: Objective: (1) Assess the feasibility of 13 N-ammonia cardiac PET (13 N-ammonia-PET) imaging in radiotherapy (RT) treatment position in locally-advanced breast cancer (LABC) patients. (2) Correlate pre−/post-RT changes in myocardial flow reserve (MFR) with the corresponding radiation heart dose. Methods: Ten left-sided LABC patients undergoing Volumetric Modulated-Arc-Therapy (VMAT) to chest wall and regional lymph nodes underwent a rest/stress 13 N-ammonia-PET at baseline and (median) 13 months post-RT. Changes in cardiac functions and coronary artery Ca2+ scoring between baseline and follow-up were correlated with average RT dose to the myocardium,3 coronary territories, and 17 myocardial segments. Results: Eight (of 10) patients successfully completed the study. The average rest (stress) global MBF (ml.g-1.min-1) for baseline (follow-up) were 0.83 ± 0.25 (2.4 ± 0.79) and 0.92 ± 0.30 (2.76 ± 0.71), respectively. Differences in MBF, heart rate, blood pressure, and rate-pressure product (RPP) between baseline and follow-up were insignificant (P > 0.1).Strong (R = 0.79; P < 0.01) and moderate (R = 0.53; P = 0.37) correlation existed between MBF Rest and MBF Stress, and RPP respectively. Four patients showed a reduction in MFR of up to ~41% in follow-up studies, increasing to ~52% in myocardial segments close to high-radiation isodose lines in 5/8 patients. Agatston Ca + 2 scoring were zero in both baseline and follow-up in six patients; two patients exhibited mild increase in Ca + 2 on follow-ups (range:10–20).Rest and stress LVEF's were normal (>50) for all patients in both studies. Conclusion: The feasibility of 13 N-ammonia-PET imaging in treatment position of LABC patients was demonstrated. MFR at 1-year post-irradiation of the heart decreased in 50% of the patients. MFR may be a potential index for early detection of cardiotoxicity in BC patients receiving RT to the chest wall. © 2020
Keywords: follow-up studies; radiotherapy; calcium; intensity-modulated radiotherapy; medical imaging; cardiotoxicity; blood pressure; heart; diseases; volumetric modulated arc therapy; ammonia; cardiac functions; locally advanced breast cancer; coronary arteries; 13n-ammonia pet; cardiac pet imaging; rate-pressure product
Journal Title: Clinical Imaging
Volume: 68
ISSN: 0899-7071
Publisher: Elsevier Inc.  
Date Published: 2020-12-01
Start Page: 283
End Page: 290
Language: English
DOI: 10.1016/j.clinimag.2020.07.026
PROVIDER: scopus
PUBMED: 32919154
PMCID: PMC8207896
DOI/URL:
Notes: Josef J. Fox's first name is misspelled on the original publication -- Article -- Export Date: 1 October 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Josef J Fox
    71 Fox
  2. Simon Nicholas Powell
    331 Powell
  3. Heiko Schoder
    542 Schoder
  4. Anthony Yu
    90 Yu
  5. Dipti Gupta
    55 Gupta